FMFrank Christoph Mooren

Frank Christoph Mooren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Frank Christoph Mooren has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Machine Learning Approach to Predict Mortality in Patients Enrolled in Cardiac Rehabilitation After Percutaneous Coronary Intervention for Acute Coronary Syndrome

    by Dimitris Gatsios, Manuela Sestayo-Fernández, Nikos Pappas, Ed De Kluiver, Arnoud W. J. Van’T Hof, Frank C. Mooren, Vassilis Tsakanikas, Carlos Pena-Gil, Boris Schmitz

    Background and Aims: Patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI) have a residual risk of adverse events and all-cause mortality. Machine learning (ML) approaches may help integrate clinical, functional, and lifestyle information for risk assessment. This study aimed to develop and externally evaluate models for predicting all-cause mortality in patients enrolled in cardiac rehabilitation after PCI for ACS. Methods and Results: Data from 1261 patients (mean age 61 ± 11.1 years, 16.6% women) enrolled in cardiac rehabilitation after PCI for ACS were analysed using seven prediction algorithms and repeated stratified cross-validation. External validation was performed using the EU-CaRE dataset of 1386 patients and predictions were explained using the model-agnostic SHapley Additive exPlanation (SHAP) methodology. LightGBM and Random Forest achieved the highest AUC and balanced accuracy (mean AUC > 0.8). SVM also exceeded logistic regression on AUC, though logistic regression remained competitive. LightGBM achieved a balanced accuracy of 0.87, sensitivity of 0.86, and specificity of 0.88. External evaluation yielded sensitivity of 0.78 and specificity of 0.73 in the PCI-treated cohort; specificity was 0.60 in the broader CAD cohort. After omission of predictors unavailable in EU-CaRE, the AUC was 0.816 with seven and 0.812 with six predictors. The highest SHAP values for impact on the model were detected for the variables “diabetes”, “physical exercise capacity (METs achieved during stress test)”, “average daily sitting duration”, “statin use”, “history of family heart disease”, “number of affected vessels”, “revascularization history”, “serum creatinine levels”, and “chronic hepatopathy”. The model was rated as “neutral” using the independent validation screening tool. Conclusions: ML models showed potential for predicting all-cause mortality in patients enrolled in cardiac rehabilitation after PCI for ACS. After prospective validation and assessment of clinical utility, the model may support clinicians in identifying patients at higher risk who could benefit from intensified treatment and lifestyle interventions. The small number of deaths and limitations of the evaluation procedure warrant cautious interpretation.

  • Post-COVID-19 Syndrome

    by René Garbsch, Boris Schmitz, Frank C. Mooren

  • Open Access

    Autonomic dysfunction and vasoregulation in long COVID-19 are linked to anti-GPCR autoantibodies

    by Boris Schmitz, René Garbsch, Hendrik Schäfer, Christian Bär, Shambhabi Chatterjee, Gabriela Riemekasten, Kai Schulze-Forster, Harald Heidecke, Christoph Schultheiß, Mascha Binder, et al.


  • Open Access

    Patient-Centered Risk Prediction, Prevention, and Intervention Platform (TIMELY) to Support the Continuum of Care in Coronary Artery Disease Using eHealth and Artificial Intelligence: Protocol for a Randomized Controlled Trial

    by Mirela Habibovic, Emma Douma, Hendrik Schäfer, Manuela Sestayo-Fernandez, Tom Roovers, Xin Sun, Henrik Schmidt, Mona Kotewitsch, Jos Widdershoven, David Cantarero-Prieto, et al.

    Background: Cardiac rehabilitation (CR) programs have shown promising results in tertiary prevention. However, achieving sustained behavioral changes remains a challenge. Objective: The TIMELY project aims to develop and evaluate a personalized, artificial intelligence–driven eHealth platform and app to support sustainable behavior change during phase-3 CR, subsequently reducing cardiac risk scores. Methods: An international, multicenter, randomized controlled trial will be conducted to evaluate the effectiveness of the TIMELY integrated platform and app. A total of 360 patients with cardiac conditions will be approached to participate in the study across Germany, Spain, and the Netherlands. Patients will be randomly assigned (1:1) to either the intervention group or the control group (care as usual). The intervention group will receive fully web-based, behavior change support through the TIMELY app, with personalized exercise prescription, chatbot assistance, and monitoring devices (eg, activity watch). Both groups will continue to receive care as usual, complete validated questionnaires, undergo physical tests, and provide blood samples. Assessments will be conducted at baseline and at 3, 6, and 12 months. Results: Trial recruitment has been finalized in July 2024. A total of 358 patients have been recruited and randomly assigned to the intervention (n=180, 50.1%) or care-as-usual (n=178, 49.7%) condition. As of January 2025, the 6-month follow-up has been completed for all participants. Follow-up data collection will be completed in May 2025. Results regarding the primary and secondary objectives are expected in September 2025. Conclusions: This project will test a personalized platform and app, supported by artificial intelligence and designed to support health behavior change during phase-3 CR. It will target multiple health behaviors, with a primary focus on physical activity and fitness levels, using an integrated approach. Trial Registration: ClinicalTrials.gov NCT05955625; https://clinicaltrials.gov/ct2/show/NCT05955625 International Registered Report Identifier (IRRID): DERR1-10.2196/66283


  • Open Access

    Time Course of Inflammatory and Endocrine Factors Following a Single-Bout of High-Intensity WB-EMS – A Randomized Crossover Study

    by Marc Teschler, Evita Bothur, Nadine Samel, Melina Waranski, Rüdiger Walscheid, Boris Schmitz, Frank C. Mooren

    The aim of the study was to gain insight into the time course of whole-body electromyostimulation (WB-EMS)-induced inflammatory and endocrine factors over 72 h. Twelve healthy individuals (5 men, 7 women; 33.0 ± 12 years) randomly performed a single 20-minute high-intensity WB-EMS and a time- and intensity-matched whole-body circuit training (CT) with a 3-week wash-out period. Blood samples were taken pre- and post-training and at 1.5, 3, 24, 48 and 72 h after exercise to assess creatine kinase (CK), myoglobin, and creatinine, cell populations (red and white blood cells [RBC, WBC], thrombocytes), cytokines (interleukin IL-1Ra, IL-6, IL-10, monocyte chemoattractant protein 1 [MCP-1]), angiogenic factors (IL-8, vascular endothelial growth factor [VEGF], thrombospondin), adipokines (leptin, adiponectin), and hormones (testosterone, cortisol). WB-EMS induced significant CK elevations peaking at 72 h (WB-EMS, 18,358 ± 21,380 vs. CT, 186 ± 129 U/l; time × group, p < .001) and increased MCP-1 after 3 h (time × group, p < .05). Both protocols induced similar effects on WBC, RBC, IL-1Ra, IL-8, leptin, and cortisol (overall time effect, all p < .01). WBC increased at 1.5 and 3 h (p < .001) and RBC decreased over 72 h (p < .05). IL-1Ra peaked at 1.5 h (p < .01) and IL-8 was elevated at 3-72 h (p < .05). The cortisol and leptin decreases lasted up to 48 and 72 h, respectively (p < .05). Despite inducing muscle damage, a single of high-intensity WB-EMS session did not lead to significantly different inflammatory and hormonal signaling compared to an acute aerobic CT session. Prolonged studies are needed to investigate whether regular WB-EMS leads to more pronounced training adaptations despite similar signaling signatures.


  • Open Access

    A Behavioral Change–Based Mobile Intervention for Promoting Regular Physical Activity in Medical Rehabilitation Maintenance of Patients With Coronary Artery Disease: Controlled Trial

    by Melina Waranski, René Garbsch, Mona Kotewitsch, Marc Teschler, Boris Schmitz, Frank C Mooren

    Background: Cardiac rehabilitation is known to reduce coronary artery disease (CAD) severity and symptoms, but adoption of a healthy postrehabilitation lifestyle remains challenging. Innovative eHealth solutions could help, but behavioral change–based eHealth maintenance programs for patients with CAD are scarce. RehaPlus+ aims to improve postrehabilitation outcomes with a personalized eHealth intervention built on behavioral change concepts emphasizing healthy lifestyle changes, especially regular physical activity (PA). Objective: This study aims to evaluate the effectiveness of the personalized eHealth program RehaPlus+ for promoting regular PA against usual care. Methods: A total of 169 patients with CAD who had undergone stent implantation or bypass surgery were recruited after completing center-based phase II rehabilitation. They were then divided, without blinding, into 2 groups using a quasi-experimental approach: a case manager–assisted 24-week eHealth program (RehaPlus+; n=84) and a conventional physician-assisted outpatient program (usual care; n=85). The study was designed as a noninferiority trial. RehaPlus+ participants received motivational messages twice weekly for 6 months, and the usual care group engaged in a 6-month outpatient program (twenty-four 90-minute strength and endurance training sessions). The primary outcomes, evaluated using the self-assessed Bewegungs- und Sportaktivität questionnaire, were regular PA (≥150 min/wk) and weekly activities of daily living (ADLs) 6 months after rehabilitation. Secondary outcomes involved PA during work and floors climbed weekly (measured by Bewegungs- und Sportaktivität questionnaire), psychological well-being (assessed by the 5-item World Health Organization Well-Being Index), cardiac self-efficacy, health-related quality of life (measured by the 36-Item Short Form Survey), and work ability (using the Work Ability Index). Results: Data of 105 patients (RehaPlus+: n=44, 41.9%; usual care: n=61, 58.1%; male patients: n=80, 76.2%; female patients: n=25, 23.8%; mean age 56.0, SD 7.3 years) were available at the 6-month follow-up. At 6 months after discharge from phase II cardiac rehabilitation, the RehaPlus+ group exhibited 182 (SD 208) minutes per week of PA and the usual care group exhibited 119 (SD 175) minutes per week of PA (P=.15), with no interaction effect (P=.12). The RehaPlus+ group showed an ADL level of 443 (SD 538) minutes per week compared to the usual care group with 308 (SD 412) minutes per week at the 6-month follow-up, with no interaction effect (P=.84). The differences observed in PA and ADL levels between the RehaPlus+ and usual care groups were within the predefined 1-sided noninferiority margin, indicating that the RehaPlus+ intervention is not inferior to usual care based on these outcomes. There were no differences between the groups for all secondary outcomes (P>.05). Conclusions: RehaPlus+ is not inferior to the usual care program, as both groups improved PA and ADLs to a similar extent. These findings emphasize the potential of eHealth interventions to assist in maintaining healthy lifestyles after rehabilitation. Trial Registration: ClinicalTrials.gov NCT06162793; https://clinicaltrials.gov/study/NCT06162793


  • Open Access

    The Acute, Short-, and Long-Term Effects of Endurance Exercise on Skeletal Muscle Transcriptome Profiles

    by Thomas Beiter, Martina Zügel, Jens Hudemann, Marius Schild, Annunziata Fragasso, Christof Burgstahler, Karsten Krüger, Frank C. Mooren, Jürgen M. Steinacker, Andreas M. Nieß

    A better understanding of the cellular and molecular mechanisms that are involved in skeletal muscle adaptation to exercise is fundamentally important to take full advantage of the enormous benefits that exercise training offers in disease prevention and therapy. The aim of this study was to elucidate the transcriptional signatures that distinguish the endurance-trained and untrained muscles in young adult males (24 ± 3.5 years). We characterized baseline differences as well as acute exercise-induced transcriptome responses in vastus lateralis biopsy specimens of endurance-trained athletes (ET; n = 8; VO2max, 67.2 ± 8.9 mL/min/kg) and sedentary healthy volunteers (SED; n = 8; VO2max, 40.3 ± 7.6 mL/min/kg) using microarray technology. A second cohort of SED volunteers (SED-T; n = 10) followed an 8-week endurance training program to assess expression changes of selected marker genes in the course of skeletal muscle adaptation. We deciphered differential baseline signatures that reflected major differences in the oxidative and metabolic capacity of the endurance-trained and untrained muscles. SED-T individuals in the training group displayed an up-regulation of nodal regulators of oxidative adaptation after 3 weeks of training and a significant shift toward the ET signature after 8 weeks. Transcriptome changes provoked by 1 h of intense cycling exercise only poorly overlapped with the genes that constituted the differential baseline signature of ETs and SEDs. Overall, acute exercise-induced transcriptional responses were connected to pathways of contractile, oxidative, and inflammatory stress and revealed a complex and highly regulated framework of interwoven signaling cascades to cope with exercise-provoked homeostatic challenges. While temporal transcriptional programs that were activated in SEDs and ETs were quite similar, the quantitative divergence in the acute response transcriptomes implicated divergent kinetics of gene induction and repression following an acute bout of exercise. Together, our results provide an extensive examination of the transcriptional framework that underlies skeletal muscle plasticity.


  • Open Access

    Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis

    by Boris Schmitz, Svenja Wirtz, Manuela Sestayo-Fernández, Hendrik Schäfer, Emma R Douma, Marta Alonso Vazquez, Violeta González-Salvado, Mirela Habibovic, Dimitris Gatsios, Willem Johan Kop, et al.

    Background: The use of eHealth technology in cardiac rehabilitation (CR) is a promising approach to enhance patient outcomes since adherence to healthy lifestyles and risk factor management during phase III CR maintenance is often poorly supported. However, patients’ needs and expectations have not been extensively analyzed to inform the design of such eHealth solutions. Objective: The goal of this study was to provide a detailed patient perspective on the most important functionalities to include in an eHealth solution to assist them in phase III CR maintenance. Methods: A guided survey as part of a Living Lab approach was conducted in Germany (n=49) and Spain (n=30) involving women (16/79, 20%) and men (63/79, 80%) with coronary artery disease (mean age 57 years, SD 9 years) participating in a structured center-based CR program. The survey covered patients’ perceived importance of different CR components in general, current usage of technology/technical devices, and helpfulness of the potential features of eHealth in CR. Questionnaires were used to identify personality traits (psychological flexibility, optimism/pessimism, positive/negative affect), potentially predisposing patients to acceptance of an app/monitoring devices. Results: All the patients in this study owned a smartphone, while 30%-40% used smartwatches and fitness trackers. Patients expressed the need for an eHealth platform that is user-friendly, personalized, and easily accessible, and 71% (56/79) of the patients believed that technology could help them to maintain health goals after CR. Among the offered components, support for regular physical exercise, including updated schedules and progress documentation, was rated the highest. In addition, patients rated the availability of information on diagnosis, current medication, test results, and risk scores as (very) useful. Of note, for each item, except smoking cessation, 35%-50% of the patients indicated a high need for support to achieve their long-term health goals, suggesting the need for individualized care. No major differences were detected between Spanish and German patients (all P>.05) and only younger age (P=.03) but not sex, education level, or personality traits (all P>.05) were associated with the acceptance of eHealth components. Conclusions: The patient perspectives collected in this study indicate high acceptance of personalized user-friendly eHealth platforms with remote monitoring to improve adherence to healthy lifestyles among patients with coronary artery disease during phase III CR maintenance. The identified patient needs comprise support in physical exercise, including regular updates on personalized training recommendations. Availability of diagnoses, laboratory results, and medications, as part of a mobile electronic health record were also rated as very useful. Trial Registration: ClinicalTrials.gov NCT05461729; https://clinicaltrials.gov/study/NCT05461729


  • Open Access

    A Behavioral Change–Based Mobile Intervention for Promoting Regular Physical Activity in Medical Rehabilitation Maintenance of Patients With Coronary Artery Disease: Controlled Trial (Preprint)

    by Melina Waranski, René Garbsch, Mona Kotewitsch, Marc Teschler, Boris Schmitz, Frank C Mooren

    BACKGROUND Cardiac rehabilitation is known to reduce coronary artery disease (CAD) severity and symptoms, but adoption of a healthy postrehabilitation lifestyle remains challenging. Innovative eHealth solutions could help, but behavioral change–based eHealth maintenance programs for patients with CAD are scarce. RehaPlus+ aims to improve postrehabilitation outcomes with a personalized eHealth intervention built on behavioral change concepts emphasizing healthy lifestyle changes, especially regular physical activity (PA). OBJECTIVE This study aims to evaluate the effectiveness of the personalized eHealth program RehaPlus+ for promoting regular PA against usual care. METHODS A total of 169 patients with CAD who had undergone stent implantation or bypass surgery were recruited after completing center-based phase II rehabilitation. They were then divided, without blinding, into 2 groups using a quasi-experimental approach: a case manager–assisted 24-week eHealth program (RehaPlus+; n=84) and a conventional physician-assisted outpatient program (usual care; n=85). The study was designed as a noninferiority trial. RehaPlus+ participants received motivational messages twice weekly for 6 months, and the usual care group engaged in a 6-month outpatient program (twenty-four 90-minute strength and endurance training sessions). The primary outcomes, evaluated using the self-assessed Bewegungs- und Sportaktivität questionnaire, were regular PA (≥150 min/wk) and weekly activities of daily living (ADLs) 6 months after rehabilitation. Secondary outcomes involved PA during work and floors climbed weekly (measured by Bewegungs- und Sportaktivität questionnaire), psychological well-being (assessed by the 5-item World Health Organization Well-Being Index), cardiac self-efficacy, health-related quality of life (measured by the 36-Item Short Form Survey), and work ability (using the Work Ability Index). RESULTS Data of 105 patients (RehaPlus+: n=44, 41.9%; usual care: n=61, 58.1%; male patients: n=80, 76.2%; female patients: n=25, 23.8%; mean age 56.0, SD 7.3 years) were available at the 6-month follow-up. At 6 months after discharge from phase II cardiac rehabilitation, the RehaPlus+ group exhibited 182 (SD 208) minutes per week of PA and the usual care group exhibited 119 (SD 175) minutes per week of PA (P=.15), with no interaction effect (P=.12). The RehaPlus+ group showed an ADL level of 443 (SD 538) minutes per week compared to the usual care group with 308 (SD 412) minutes per week at the 6-month follow-up, with no interaction effect (P=.84). The differences observed in PA and ADL levels between the RehaPlus+ and usual care groups were within the predefined 1-sided noninferiority margin, indicating that the RehaPlus+ intervention is not inferior to usual care based on these outcomes. There were no differences between the groups for all secondary outcomes (P>.05). CONCLUSIONS RehaPlus+ is not inferior to the usual care program, as both groups improved PA and ADLs to a similar extent. These findings emphasize the potential of eHealth interventions to assist in maintaining healthy lifestyles after rehabilitation. CLINICALTRIAL ClinicalTrials.gov NCT06162793; https://clinicaltrials.gov/study/NCT06162793